期刊文献+

国外非小细胞肺癌文献计量和研究热点分析 被引量:1

原文传递
导出
摘要 目的了解当前该病的研究状况,为广大专业人员深入开展非小细胞肺癌的研究提供参考信息。方法下载Pubmed数据库中2008-2009这2年发表的非小细胞肺癌研究文献的主题词,统计主题词出现的频次,截取频次大于198次的主题词作为高频主题词。两两统计高频主题词在同一篇文献中出现的频率,形成主题词共现矩阵,利用spss统计软件对矩阵做聚类分析,得到该主题研究热点。结果共检出2年非小细胞肺癌文献3 078篇,出现频次超过198次的主题词43个,通过对这43个高频主题词聚类得到5个研究热点。结论目前国外对非小细胞肺癌的研究热点主要集中在放疗、外科手术及化疗、诊断、病因学研究、抗肿瘤用药的研发及应用等方面。
作者 江建忠
出处 《预防医学情报杂志》 CAS 2011年第3期226-229,共4页 Journal of Preventive Medicine Information
  • 相关文献

参考文献10

  • 1朱代峰,桂淑玉.非小细胞肺癌的治疗进展[J].临床肺科杂志,2010,15(3):372-374. 被引量:14
  • 2张晗,崔雷.运用共词聚类分析法研究生物信息学的学科热点[J].医学情报工作,2004,25(5):327-330. 被引量:46
  • 3Nguyen NP, Garland L, Welsh J, et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage non2 small cell lung carcinoma[J]. Cancer Treat Rev, 2008, 34 (8) : 719-727.
  • 4Yildizeli B, Dartevelle PG, Fadel E, et aL Results of primary surgery with T4 non - small cell lung cancer during a 252 year period in a single center : the benefit isworth the risk[J]. Ann Thorac Surg, 2008, 86 (4) : 1065-1075, discussion 1074-1075.
  • 5Bunn PA Jr, Thatcher N. Systemic treatment for advanced ( stage Ⅲb/Ⅳ) non- small cell lung cancer: more treatment options; more things to consider[J]. Conclusion Oncologist, 2008, 13(S1): 37-46.
  • 6Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non - small - cell lung cancer: a randomised, double - blind, phase 3 study[J]. Lancet, 2009, 374(9699): 1432-1440.
  • 7Rabinowits G, Gercel Taylor C, Day JM. Exosomal microRNA: a diagnostic marker for lung cancer [ J ]. Clin Lung Cancer, 2009, 10 (1): 42-46.
  • 8Yu SL, Chen HY, Chang GC. MicroRNA signature predicts survival and relapse in lung cancer[J]. Cancer Cell, 2008, 13 ( 1 ) : 48-57.
  • 9Nasser MW, Datta J, Nuovo C. Down - regulation of micro - RNA - 1 ( miR - 1 ) in lung cancer. Suppression of tumorigenic property of lung cancer ceils and their sensitization to doxorubicin - induced apoptosis by miR-1[J]. J Biol Chem, 2008, 283 (48): 33394-33405.
  • 10Blumenschein GR Jr, Gatzemeier U, Fossella F, et al. Phase Ⅱ, multicenter, uncontrolled trial of single - agent sorafenib in patients with relapsed or refractory, advanced non - small - cell lung cancer [ J ]. J Clin Oncol, 2009, 27 (26): 4274-4280.

二级参考文献31

  • 1唐焕文,靳利霞.生物信息学的产生、发展及应用前景[J].洛阳师范学院学报,2001,20(2):133-136. 被引量:6
  • 2崔雷.专题文献高频主题词的共词聚类分析[J].情报理论与实践,1996,19(4):49-51. 被引量:149
  • 3Gharagozloo F, Margolis M, Tempesta B. Robot-assisted thoracoscopic lobectomy for early-stage lung cancer. Ann Thorac Surg, 2008,85:1880 - 1886.
  • 4Yildizeli B, Dartevelle PG, Fadel E, et al. Results of primary surgery with T4 non-small eell lung cancer during a 25-year period in a single center:the benefit is worth the risk. Ann Thorae Surg,2008, 86 (4) : 1065 - 75 ; discussion 1074 - 1075.
  • 5Scagliotti GV, Pastorino U, Vansteenkiste JF, et al. A phase Ⅲ randomized study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in early-stage non-small cell lung cancer (NSCLC) : Follow-up data of Ch E S T. J Clin Oncol, 2008,26 : ( suppl ) : abstr 7508.
  • 6Bunn PA Jr, Thatcher N. Systemic trestment tor advanced ( stage Ⅲb/Ⅳ) non-small cell lung cancer: more treatment options:more things to consider. Conclusion. Oncologist,2008,13 Suppl 1 : 37 - 46.
  • 7Fessdla F, Pereim JR, von Pawel J, et al. Randomized, multinational, phase Ⅲ studv of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non - small - cell lung cancer: the TAX 326 study group. J Clin Oncol, 2003, 21 : 3016 - 3024.
  • 8Ciuleanu TE, Brodowicz T, Belani CP, et al. Maintenance pemetrexed plus best suppporive care(BSC) versus placebo plus BSC :A phase Ⅲ study. J Clin Oncol, 2008, 26 : ( Suppl, abstr 801 Ⅰ).
  • 9Hendry JH, Bentzen SM, Dale RG, et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol, 1996,8 (2) :297 - 307.
  • 10Nguyen NP, Garland L, Welsh J, et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage nonsmall cell lung carcinoma. Cancer Treat Rev, 2008,34 ( 8 ) : 719 - 727.

共引文献58

同被引文献10

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部